Yulp, that answers that.
The big FDA run has been played.
The next big run comes when they sell the entire Company, or they try and sell the product themselves.
The PP means the latter.
This is the new bottom and where getting out on the FDA news is the reload area.
Could go sideways for a long time.
I much prefer a Novartis type buy out, but time to become a business.
Let's see if it sells.
It's money I the bank here, regardless what happens.